3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Melanoma
2
Malignant Solid Neoplasm
2
Hematopoietic and Lymphatic System Neoplasm
2
Hematologic Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
COVID-19
2
Urologic Neoplasms
1
Urologic Diseases
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Teratoma
1
Stomatitis
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Renal Insufficiency, Chronic
1
Psoriasis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peritoneal Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Mouth Neoplasms
1
Interventions
Oxaliplatin
10
Leucovorin
9
Fluorouracil
9
Specimen Handling
6
Cetuximab
6
Bevacizumab
6
Magnetic Resonance Spectroscopy
4
pembrolizumab
3
cemiplimab
3
Pemetrexed
3
fludarabine
2
dehydroftorafur
2
aldesleukin
2
Surveys and Questionnaires
2
Nivolumab
2
Irinotecan
2
Immunoglobulin G
2
Gemcitabine
2
Folfox protocol
2
Disulfides
2
Cyclophosphamide
2
Cisplatin
2
Carboplatin
2
Biopsy
2
ulixertinib
1
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
tipiracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Practice Guidelines as Topic
×
30 days
×
Clear all
No trials found.